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Abstract
In Gram-negative bacterial pathogens, specialized chaperones bind to secreted effector proteins and maintain them in a
partially unfolded form competent for translocation by type III secretion systems/injectisomes. How diverse sets of effector-
chaperone complexes are recognized by injectisomes is unclear. Here we describe a new mechanism of effector-chaperone
recognition by the Chlamydia injectisome, a unique and ancestral line of these evolutionarily conserved secretion systems. By
yeast two-hybrid analysis we identified networks of Chlamydia-specific proteins that interacted with the basal structure of the
injectisome, including two hubs of protein-protein interactions that linked known secreted effector proteins to CdsQ, the
putative cytoplasmic C-ring component of the secretion apparatus. One of these protein-interaction hubs is defined by Ct260/
Mcsc (Multiple cargo secretion chaperone). Mcsc binds to and stabilizes at least two secreted hydrophobic proteins, Cap1 and
Ct618,thatlocalizetothemembraneofthepathogenicvacuole(‘‘inclusion’’).TheresultingcomplexesbindtoCdsQ,suggesting
that in Chlamydia, the C-ring of the injectisome mediates the recognition of a subset of inclusion membrane proteins in
complex with their chaperone. The selective recognition of inclusion membrane proteins by chaperones may provide a
mechanism to co-ordinate the translocation of subsets of inclusion membrane proteins at different stages in infection.
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Introduction
The obligate, intracellular bacterium Chlamydia trachomatis infects
the epithelium of the genital tract and conjunctivae, causing a wide
range of ailments including the blinding disease trachoma,
conjunctivitis, salpingitis, pelvic inflammatory disease and infertil-
ity [1]. Chlamydiae display an elaborate life cycle beginning with the
attachment of an elementary body (EB), the infectious form of the
bacteria, to the surface of epithelial cells [2]. Shortly after invasion,
EBs differentiate into reticulate bodies (RBs). The RB-containing
vacuole is rapidly segregated from normal endosomal maturation
pathways to generate a membrane-bound ‘‘inclusion’’ [3]. As the
inclusion expands, chlamydial replication becomes asynchronous
to yield both RBs and EBs. Eventually, most of the cytoplasmic
space of the host cell is occupied by the inclusion and EBs exit the
host cell to infect adjacent cells [4].
AllChlamydiaecodeforthecore componentsofa typeIII secretion
(T3S) apparatus, a protein transport system used by Gram-negative
bacteria to translocate effector proteins directly into host cells [5].
T3S systems are macromolecular structures composed of 20–35
proteins that are often referred to as ‘‘injectisomes’’ due to their
resemblance to an injection needle [6]. Chlamydia injectisome
components are present at all stages of infection and needle-like
structures have been observed on the surface of EBs and at the sites
of RB attachment to inclusion membranes [7,8,9], suggesting that
this secretion system is functional. Putative chlamydial targets of
T3S have been identified by their ability to be secreted by Shigella,
Yersinia or Salmonella injectisomes [10,11,12,13]. These T3S
substrates include .25 soluble proteins and a large family of
,40–50 integral membrane proteins of unknown function that
localize to the inclusion membrane (Incs) [8,10,11,12,13]. At least
one of these effectors, Tarp, is translocated during EB invasion of
epithelial cells [10]. T3S substrates are likely translocated in a
hierarchical fashion to manipulate specific cellular functions at
distinct stages of infection [14].
Injectisomes belong to at least seven distinct families [15] of
which three (Ysc, SPI-1 and SPI-2) are predominantly found in
free-living pathogens of animals and two are more common in
plant pathogens (Hrp1 and Hrp2). The remaining injectisome
families are limited to the Chlamydiae phylum and the Rhizobiale
order [6]. In the Chlamydiales, the genes encoding the T3S
apparatus are scattered in small genomic islands [5,16]. Remark-
ably, the content and synteny of these gene clusters is largely
conserved among the Chlamydiaceae, suggesting that even though
members of this phylum diverged over 700 million years ago [17],
the genetic blueprint for the assembly of this translocation system
has remained largely intact. These findings, combined with the
lack of evidence for robust lateral gene transfer of T3S genes in
Chlamydiae, support the hypothesis that the chlamydial T3S system
is the closest to the primordial injectisome [18].
A transcriptional analysis of genes encoding chlamydial
injectisome components revealed 10 operons containing 37 genes
[16]. Recent work in C. pneumoniae indicated that interactions
among components of the basal structure of the secretion
apparatus are evolutionarily conserved [19]. For example, the
putative C-ring component, CdsQ, interacts with the cytoplasmic
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and YscQ in Yersinia [19,20]. Although many components of the
chlamydial injectisome basal structure are conserved, the needle
and needle tip components are not [21]. The identification of
needle component, CdsF, and its chaperones CdsE and CdsG,
required more sophisticated bioinformatic approaches [22,23].
Similarly, two sets of translocation pore components, CopB/CopD
and CopB2/CopD2 (CT578/CT579 and CT861/CT860, re-
spectively) were identified based on their close linkage to genes
encoding secretion chaperones and their similarity in protein
topology to the Yersinia translocators YopB and YopD [24,25,26].
The lack of a systemfor genetic manipulation inChlamydia and the
observation that chlamydial proteins cannot functionally substitute
for orthologous T3S components in other bacterial systems [24] has
limited a functional analysis of this ancestral secretion system. As a
result, little is known as to how the Chlamydia injectisome is
assembled, regulated or how the translocation of effector proteins is
temporally and spatially controlled. Here, we applied yeast two-
hybrid (Y2H) technology [27] to identify new core components,
regulators and secretory cargo of the chlamydial injectisome. In this
manner, we identified two protein-protein interaction nodes linking
multipleeffectorproteinstoCdsQ,theputativeC-ringcomponentat
the base of the injectisome. We provide evidence that one of these
protein interaction hubs is a chaperone for a subset of proteins
destined for transport to the inclusion membrane and that CdsQ
interacts with this chaperone alone and in complex with effector
proteins. We propose that the C-ring of the chlamydial injectisome
acts as a platform for the recognition and engagement of chaperones
complexed to secretory cargo.
Results
Identification of Chlamydia protein-protein interaction
networks by yeast two-hybrid analysis
The core components of the T3S apparatus are defined by 10
operons dispersed among five different loci in the chromosome
[16] (Fig. 1A). In addition, two unlinked operons encode proteins
of the T3S-related flagellar export machinery. Based on protein-
protein interactions defined among homologous components
(Table 1) in other bacterial pathogens, the chlamydial injectisome
has been proposed to have an architecture as outlined in Fig. 1B
[5,6].
To identify additional injectisome components, regulators,
secretion chaperones and their respective cargo, we screened
chlamydial proteins for their ability to interact with core
components of the injectisome by Y2H analysis. We amplified
208 Chlamydia-specific, conserved hypothetical ORFs, and genes
encoding putative effectors and injectisome components by PCR
and cloned them into Y2H vectors to generate carboxyl terminal
fusions to the DNA-binding domain (DBD) or Activator Domain
(AD) of the yeast transcription factor Gal4, respectively (Table S1).
For proteins containing large hydrophobic regions which tend to
be toxic when expressed in yeast (e.g. inclusion membrane
proteins) [28], only the putative cytoplasmic regions were
expressed. MATa and MATa yeast strains expressing chlamydial
proteins fused to Gal4AD or Gal4DBD were crossed to generate
diploid strains. Positive interactions among these fusion proteins
were identified by their ability to transcribe Gal4-dependent
reporter genes (GAL1UAS-GAL1TATA-HIS3, GAL2UAS-GAL2TATA-
ADE2) and restore growth in histidine and adenine deficient
media. We identified 49 proteins that displayed various levels of
homotypic and heterotypic interactions (Table S2). Most of these
interactions were among proteins predicted to reside at the inner
membrane and the cytoplasmic side of the basal T3S apparatus,
although homotypic and heterotypic interactions were also
observed among the predicted cytoplasmic domains of Inc
proteins, including IncA, Ct565, Ct229 and Ct223.
Identification of T3S chaperone binding partners
We predicted that secretory cargo proteins engaged by known
T3S chaperones could be identified based on protein interactions
revealed by Y2H analysis. There are three classes of T3S
chaperones: class III chaperones prevent the premature polymer-
ization of needle components in the bacterial cytoplasm [23,29].
An interaction between the needle component CdsF and its
chaperone CdsG [22] was detected in our Y2H analysis as well as
an interaction between CdsG and its co-chaperone CdsE (Fig. 1C).
Class II chaperones, which in Chlamydia include and Ct274 (LcrH/
SycD-like) and the tetratricopeptide repeat (TPR) containing Scc2
and Scc3 [24], bind to hydrophobic translocator proteins [30]. We
determined that Scc2 binds to both CopB and CopD while Scc3
binds to CopN (Fig. 1B). The interactions between Scc2/CopB
and Scc3/CopN are in agreement with previous findings [24,31].
In addition, we detected heterotypic interactions between Ct274
and a small (24 kDa), acidic (pI 4.5) protein Ct668. Ct274 also
interacted with Ct161, a homologue of the secreted protein Lda2
[32] (Fig. 1C).
Class I chaperones are small (,15 kDa), acidic (pI,5) proteins
that assemble mostly as homodimers to bind effector proteins [25].
These chaperones have been further subclassified depending on
whether they associate with one (class Ia) or several (class Ib)
effectors [33]. By amino acid sequence analysis, C. trachomatis
encodes at least three putative T3S chaperones: Ct043, Ssc1 and
Ct663 (SycE/CesT-like). Unlike their counterparts in other
pathogenic bacteria, we did not detect many homotypic
interactions among chlamydial class I T3S chaperones. Instead,
we found evidence of potential heterodimeric complexes, includ-
ing an Scc1-Ct663 interaction.
Overall, these results suggest that chlamydial homologues of
Class 1 T3S chaperones may form heterodimeric complexes and
Author Summary
The obligate intracellular bacteria Chlamydia trachomatis is
a common sexually transmitted pathogen and the leading
cause of preventable blindness worldwide. Chlamydia co-
opts host cells by secreting virulence factors directly into
target cells through a multi-protein complex termed a type
III secretion systemor ‘‘injectisome’’.Thelack of a systemfor
molecular genetic manipulation in these pathogens has
hindered our understanding of how the Chlamydia injecti-
some is assembled and how secreted factors are recognized
and translocated. In this study, a yeast two-hybrid approach
was used to identify networks of Chlamydia proteins that
interact with components of the secretion apparatus. CdsQ,
a conserved structural component predicted to be at the
base of the injectisome, interacted with multiple proteins,
including a new chaperone that binds to and stabilizes
secretory cargo destined for the membrane of the
pathogenic vacuole. These results suggest that the base
of the secretion apparatus serves as a docking site for a
chaperone and a subset of chaperone-cargo complexes.
Because the chlamydial injectisome represents a unique
and ancestral lineage of these virulence-associated secre-
tion systems, findings made in Chlamydia should provide
unique insights as to how effector proteins are recognized
and stabilized, and how a hierarchy of virulence protein
secretion may be established by Gram-negative bacterial
pathogens.
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partners. However, given that ,10% of the chlamydial coding
potential may be devoted to T3S substrates,[12,34,35,36] it is
apparent that the number of effector proteins is in excess of
potential chaperones. This indicates that the secretion of many
chlamydial T3S substrates is either chaperone-independent or that
many secretion chaperones remain to be identified.
The C-ring component CdsQ is a central hub of multiple
protein-protein interactions
CdsQ (Ct672), a homologue to the C-ring component FliN of
the Salmonella flagellar apparatus [37] and the Shigella Spa33
protein [38], represented a central node of Chlamydia protein-
protein interactions (Fig. 1D). CdsQ interacted with CdsL, an
interaction that is conserved among related components in Yersinia,
Shigella, and enteropathogenic E. coli (EPEC) injectisomes
[20,38,39]. CdsS and CdsT were also observed to interact with
CdsQ (Fig. 1D). These proteins are predicted to reside at the inner
membrane and likely interact as components of the inner
membrane spanning ring in other bacterial pathogens [40,41].
An interaction between CdsQ, CdsL and CdsD has been recently
reported in C. pneumoniae [19]. Unfortunately, we were unable to
detect CdsD interacting proteins because this protein was self-
activating in our Y2H reporter system. Additional components of
the basal T3S apparatus may include the CdsQ-interacting
proteins Ct560 and Ct567, an ORF immediately adjacent to this
operon (Fig 1A). CdsQ did not interact with CdsV (Ct090), a
conserved injectisome inner membrane protein, but did interact
with the CdsV/FlhA homologue Ct060 (Fig. 1D). This raises the
possibility that the Chlamydia injectisomes may be formed by a
mixture of flagellar and T3S components. A combinatorial
assembly of injectisomes may enhance the functionality of the
secretion apparatus by adding assembly control checkpoints or by
expanding the repertoire of cargo proteins that can be secreted.
We did not detect several of the predicted interactions among
integral membrane components of the injectisome or the secretin
CdsC. The inability to detect such interactions is likely due to the
limitations of the classical Y2H system in identifying interactions
among integral membrane proteins and proteins destined to fold
outside of cytoplasmic compartments [42]. Nonetheless, we
detected interactions between the needle component CdsF and
its chaperones, CdsG and CdsE [22], and Ct584, a conserved
chlamydial ORF (Fig. 1C). We postulate that these interactions
were detected because they most likely occur in the bacterial
cytoplasm.
Despite the known limitations of classical Y2H analysis, our
ability to identify previously reported interactions validate the
utility of this approach. Importantly, novel interactions identified
by Y2H suggest that CdsQ may play a central role in organizing
networks of proteins at the base of the injectisome, including
secreted effectors.
Ct260 and its interacting partners localize to distinct
subcellular sites
T3S effectors require secretion chaperones for efficient
translocation by injectisomes [43,44]. ATPases in Yersinia and
Salmonella, YscN and InvC respectively, recognize chaperone-
effector complexes and provide the energy for their dissociation,
thus facilitating effector protein export [45,46]. Similarly, the inner
membrane component YscU in Yersinia recognizes translocators as
Figure 1. Yeast two-hybrid analysis defines hubs of protein-protein interactions linking the Chlamydia injectisome to secreted
effectors. (A). Operon arrangement of conserved component of the C. trachomatis type III secretion system (T3SS) [16]. Light grey: secreted proteins,
Dark grey: T3S chaperones (B). Proposed architecture of the Chlamydia injectisome. Assignments were made based on protein interactions conserved
in other bacterial T3SS [6] and as proposed in [5]. Cds: contact dependent secretion protein, Cop: chlamydial outer protein. (C). Interactions between C.
trachomatis T3S chaperones and their putative cargo. Protein-protein interactions were identified based on reciprocal YTH interactions. (D).
Identification of interactions among core components of the C. trachomatis T3S apparatus, chlamydial proteins of unknown function and known effector
proteins. Networks of putative interacting proteins were identified by Y2H analysis (Table S2). Self-interactions are denoted by arcs.
doi:10.1371/journal.ppat.1000579.g001
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components at the base of the injectisome provide a platform for
the recognition of secretory cargo.
Based on these observations, two chlamydial protein-protein
interaction hubs linking known secreted effector proteins to CdsQ
were of particular interest. In the first interaction node, Ct700, via
its TPR repeat domain could act as a scaffold to dock effectors
directly (e.g. Ct223 and Ct226) [34,35] or indirectly (IncA and
Lda2) [32,48]. These protein interaction networks are linked to
CdsQ via the putative protease, Ct824 (Fig. 1D). The relevance of
these interactions in vivo remains to be determined. The other
protein-protein interaction hub has Ct260 at its center and links
CdsQ to the inclusion membrane proteins Cap1 [49], Ct618 [28]
and Ct225 [35] (Fig. 1D). Cap1 has been postulated to be a
secretion target of the chlamydial injectisome because fusion of the
first 15 amino acids of Cap1 to adenylate cyclase is sufficient to
impart T3S-dependent export of the fusion protein in Shigella [12].
To validate the novel interactions identified by Y2H, we
decided to characterize the putative bindings of Ct260 to CdsQ
and the secreted effectors Ct618 and Cap1 (Fig. 2A). We
generated specific antisera to Ct260, and CdsQ, and determined
by immunoblot analysis that these proteins are expressed in
infected cells and in density gradient purified EBs and RBs
(Fig. 2B&C). Next, we determined the subcellular localization of
Figure 2. Components of a Chlamydia injectisome protein-protein interaction hub localize to distinct subcellular sites. (A). Network of
predicted Ct260 (Mcsc) protein-protein interactions. Interactions were defined by Y2H analysis as described in Fig. 1D. (B–C). Ct260 and CdsQ are
expressed throughout infection.( B). HeLa cells were infected with C. trachomatis and total protein samples collected at various times post-infection.
Ct260, the bacterial major outer membrane protein (MOMP), and the inclusion membrane proteins IncA and Cap1 were detected with specific
antibodies. Tubulin levels were serve as protein loading controls. (C). Reticulate bodies (RBs) and EBs were purified from infected cells by density
gradient and total proteins were analyzed by immunoblot analysis with antibodies against the indicated chlamydial proteins. (D–E). Ct260 and CdsQ
partition with membranes and hydrophobic proteins.( D). EBs were extracted with Triton-X114 to separate membrane from non-membrane associated
proteins. Ct260 partitioned with the detergent fraction along with integral membrane proteins CdsJ and MOMP, but not the cytoplasmic proteins
Hsp60 and RpoD. CdsQ partitioned in both membrane and aqueous fractions. (E). Ct260 is sensitive to Sarcosyl extraction, a detergent that solubilizes
all membrane proteins except COMC, suggesting a lack of association with chlamydia outer membrane complexes (COMC) (F–G). Ct260 is not a target
of T3S.( F). Secretion of T3S was induced by treatment of EBs with 0.5% BSA and 10mM EGTA. Tarp, but not Ct260, was detected in the extracellular
media. (G). CdsQ and Ct260 localize to bacteria while Cap1 and Ct618 localize to the inclusion membrane. Ct260 and CdsQ (red) were observed
exclusively in association with MOMP or LPS-positive (green) bacteria at early (12 h) and late (24 h) post-infection. Ct618 and Cap1 (red) localize to
the extra-bacterial structures, including inclusion membranes. Scale bar range: 1.5 mm (12 h) to 4 mm (24 h). Abbreviations: (h.p.i.) hours post
infection, (T) total lysates from purified EBs, (Memb.) and (Aq.) represent the detergent and aqueous phase of Triton-X114 extraction, (S) and (P)
denote the soluble and insoluble protein fractions extracted with Sarcosyl respectively. Mcsc: Functional nomenclature for Ct260 (See Fig. 3).
doi:10.1371/journal.ppat.1000579.g002
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upon extraction from EBs with Triton-X114 or Sarcosyl [50,51].
CdsQ and Ct260 phase partitioned with Triton-X114 indicating
an association with hydrophobic proteins (Fig. 2D), although a
significant portion of CdsQ was also present in the aqueous, non-
hydrophobic phase. Any association of Ct260 with membranes is
unlikely to include chlamydial outer membrane complexes
(COMC) since the protein was readily extracted from EBs with
Sarcosyl (Fig. 2E). Given its association with CdsQ and
translocated effectors, Ct260 could be a core T3S component or
a secreted effector. We tested the ability of Ct260 to be secreted
from EBs by adapting a recently described in vitro secretion system.
In this system, EB effectors are released into the culture
supernatant by treatment with calcium chelators and bovine
serum albumin at 37uC [52]. Under these conditions Ct260 was
not released into the extracellular media, while Tarp, a known
secreted effector, was efficiently secreted (Fig. 2F), suggesting that
at least in EBs, Ct260 is not an efficient target of T3S.
We performed a detailed analysis of Ct260, CdsQ, Cap1 and
Ct618 localization at 12 and 24 h post infection by immunoflu-
orescence microscopy. Consistent with the fractionation experi-
ments (Fig. 2D&E), CdsQ and Ct260 associated exclusively with
bacteria, while Ct618 and Cap1 were found at the inclusion
membrane, even at early time points (Fig. 2G). Overall, these
results indicated that at steady state, Ct260 and CdsQ reside
within the confines of bacterial cells, while Ct618 and Cap1 are
largely exported. Therefore, any interaction between Ct260 and
C618 or Cap1 is likely to be transitory and occur in the bacterial
cytoplasm or in association with bacterial cytoplasmic membranes.
Ct260/Mcsc (Multiple cargo secretion chaperone)
stabilizes Ct618 and Cap1
PSI-BLAST-based database searches of Ct260 did not reveal
homology to any known proteins. However, given that Ct260 is a
small (18.8 kDa), acidic (pI 4.6) protein that interacted with itself
and T3S effectors by Y2H analysis (Fig. 2A), we hypothesized that
it was a secretion chaperone. In support of this, the predicted
secondary structure of Ct260 has a similar arrangement of a-
helices and b-strands as T3S chaperones (Fig. S1). We propose
that Ct260 is a new T3S secretion chaperone, and thus refer to it
as Multiple cargo secretion chaperone (Mcsc).
We first tested if recombinant Mcsc formed homotypic
complexes by treating recombinant protein with low levels of the
chemical crosslinker DSP on ice and assessing the formation of
higher molecular weight complexes by SDS PAGE and immuno-
blots. Mcsc was readily cross-linked into a major 36 kDa
molecular weight species consistent with the formation of a dimer
(Fig. 3A). This dimeric form of Mcsc was seen even in the absence
of chemical crosslinkers (Fig. 3A) and its relative abundance was
sensitive to heat and reducing agents (not shown). Higher order
complexes consisting of potential trimers and tetramers were also
observed at the highest concentration of crosslinker. The relevance
of these higher order complexes is not clear since we have
observed a cold-induced aggregation of purified Mcsc (not shown).
Next, we determined if Mcsc associated with the effectors Cap1
and Ct618 by co-expressing untagged Mcsc and a hexahistidine-
tagged versions of full-length Cap1 (aa 1–298) and the amino-
terminal domain of Ct618 (aa1–189) from bicistronic vectors.
Mcsc efficiently co-purified with 6xHis-tagged Ct618 or Cap1 on
Ni
2+ NTA resin, suggesting a stable interaction between these
inclusion membrane proteins and the putative chaperone (Fig. 3B).
We sized these complexes by gel filtration chromatography and
determined that when expressed alone, Mcsc eluted as a ,35 kDa
complex, a size consistent with that of the dimeric forms identified
in cross-linking experiments (Fig. 3C). In contrast, when Mcsc was
co-expressed with Cap1 or Ct618, it fractionated as a protein
complex of 66–78 kDa and 54–65 kDa respectively (Fig. 3C). The
size of these complexes is consistent with that of two Mcsc subunits
bound to one effector protein.
Next, we tested if Mcsc could bind to full-length Cap1 from
infected cell lysates. We incubated NP40 solubilized membranes
from infected cells with recombinant 6xHis-tagged Mcsc dimers,
and assessed the ability of endogenous Cap1 to be purified on
Ni
2+NTA agarose. Cap1, but not the inclusion membrane proteins
IncA, specifically bound to Ni
2+-beads in the presence of Mcsc
(Fig. 3D).
We mapped the regions of Ct618 and Cap1 that interact with
Mcsc by Y2H analysis. Truncated forms of Ct618 and Cap1 were
fused to the GAL4DBD and co-expressed in yeast with GAL4AD-
Mcsc. Positive interactions were assessed by growth in histidine or
adenine deficient media as described above. A region encompass-
ing the central region of both Ct618 and Cap1 was sufficient to
mediate an interaction with Mcsc (Fig. 3E). The Mcsc binding site
on its secretory cargo (Ct618 and Cap1) is within the range of what
has been observed in other chaperone-effector protein complexes
[44].
Our initial attempts at purifying recombinant Cap1 and Ct618
indicated that these proteins were not stable when expressed at
high levels in E.coli. Given our finding that Mcsc may constitute a
chaperone for these effectors, we compared the effect of expressing
Cap1 and Ct618 with or without Mcsc from mono and bicistronic
E. coli expression vectors under the control of a T7 promoter
(Fig. 4A). Consistent with our earlier observations, the detected
levels of Cap1 and Ct618 protein were significantly lower in the
absence of Mcsc (Fig. 4B). Interestingly, Cap1 and Ct618 migrated
at a higher apparent molecular weight in the absence of Mcsc
(Fig. 4B), suggesting that in the presence of the chaperone, these
inclusion membrane proteins may be subjected to conformational
changes that expose susceptible regions to E. coli proteases.
Although this processing may be specific to E. coli, it is clear that
the expression and stability of Cap1 and 618 is dependent on
Mcsc, thus establishing its role as a chaperone.
Based on the crystal structures of various class I secretion
chaperones, conserved hydrophobic amino acids in the first a-
helix and b-strand are proposed to be important for the
recognition of secretory cargo [44]. We identified the correspond-
ing amino acids in Mcsc (Fig. 4C & S1) and tested if these residues
played a role in the binding of Mcsc to Ct618 and Cap1. First, we
generated point mutation in Mcsc’s a1-helix (L15A) and b1-strand
(I31A, I33A V35A (‘‘3A’’) and I31G, I33G V35G (‘‘3G’’)) and
tested the ability of these mutants to interact with effectors by
Y2H. Consistent with their proposed role in binding substrates, all
three mutations in Mcsc significantly impaired interactions with
Cap1 and Ct618 (Fig. 4D). Next, we introduced these mutations
into Mcsc-Cap1 and Mcsc-Ct618 bi-cistronic E. coli expression
vectors (Fig. 4A). The 3A and 3G mutations did not affect the
expression of Mcsc (Fig. 4E) or its ability to form dimers (not
shown). However, co-expression of 3A and 3G Mcsc mutants led
to significantly lower levels of Ct618 and Cap1 (Fig. 4E) as assessed
by immunoblot analysis of total protein lysates. In contrast, co-
expression with the L15A Mcsc mutant had little effect on the total
amounts of Cap1observed but Ct618 was not detectable (Fig. 4D).
We tested if these mutants were still capable of binding either
hexahistidine tagged Cap1 or Ct618 by co-isolating effector
complexes on Ni-NTA agarose beads. As shown in Fig. 4D, Mcsc
and Mcsc mutants co-purified with Cap1 in a manner propor-
tional to the levels of Cap1 present in the total lysates. Not
surprisingly, Mcsc mutants did not co-purify with Ct618, since the
Recognition of Secretion Chaperones
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that Mcsc 3A and 3G mutants had a much greater impact on
Cap1 and Ct618 expression levels than the absence of Mcsc,
suggesting that Ct618 and Cap1 levels are directly affected by their
interaction with Mcsc (Fig. 4B & E). We postulate that 3A and 3G
Mcsc mutants, like the wild type counterpart, still provides a
platform for the binding of Cap1 and Ct618, but the binding
interaction is not strong enough to prevent their dissociation from
Mcsc and eventual degradation.
CdsQ binds to Mcsc and Mcsc-Cap1 protein complexes
T3S chaperones are proposed to play a role in targeting
secretory cargo to the injectisome, either by providing new
targeting information [53], or facilitating the exposure of the short
amino terminal export signal [6]. Based on these findings we were
intrigued by the significance of Mcsc-CdsQ interactions identified
by Y2H. First, we confirmed these interactions by demonstrating
that purified Mcsc dimers efficiently bound to GST-CdsQ,
indicating that the presence of the effector is not required for
Mcsc to engage the C-ring (Fig. 5A). Next, we tested if CdsQ can
bind to Mcsc-effector complexes by incubating GST-CdsQ with
Mcsc-Cap1 complexes isolated by gel filtration chromatography.
A complex of Mcsc and Cap1 co-eluted from glutathione
sepharose beads when incubated with GST-CdsQ but not GST
alone (Fig. 5B). Based on CdsQ’s homology to the C-ring
component Spa33, which localizes to the base of Shigella
injectisome [38], we postulate that CdsQ associates with the base
of the chlamydial secretion needle apparatus and provides a
platform for the recognition of Mcsc and Mcsc-effector protein
complexes.
Figure 3. Ct260/Mcsc (Multiple cargo secretion chaperone) dimers bind to the inclusion membrane proteins Cap1 and Ct618. (A).
Mcsc forms a dimer. Hexahistidine-tagged –Mcsc (Ct260) was treated with various concentrations of the reversible crosslinker DSP, resolved on a 4–
20% gradient gel and probed with Mcsc specific antibodies. Arrow marks the dimeric form of Mcsc, which was reduced to monomeric form after
boiling in the presence of DTT. (B–C). Mcsc-Cap1 and Mcsc-Ct618 co-purify as complexes.( B). Lysates of E. coli expressing 6xHis-tagged Mcsc or co-
expressing Mcsc and 6xHis-tagged Ct618 (aa1–189) or Cap1 (aa1–298) were incubated with Ni
2+-NTA agarose beads. Bound proteins were eluted
with 150 mM imidazole and detected by SDS PAGE and Coomassie staining. Mcsc co-purified with Ct618-6xHis and Cap1-6xHis on Ni
2+ beads. The
numbers above the lanes represent fractions collected after incubation with wash buffer or elution buffers. Untagged Mcsc does not bind to the
nickel columns non-specifically (Fig. 4E). (C). Proteins eluted from affinity columns were further fractionated by gel filtration chromatography. Mcsc
eluted from the column at a size of ,34 kDa. Mcsc-Cap1 and Mcsc/Ct618 eluted as complexes of ,66 kDa and 54 kDa, respectively. The identity of
all eluted proteins was confirmed by immunoblot analysis with anti Mcsc, Cap1 and hexahistidine tags. (D). Mcsc binds to endogenous Cap1 from
infected cells. Lysate of infected HeLa cells were incubated with purified Mcsc dimers pre-bound to Ni
2+-NTA agarose beads, and proteins were eluted
with 150 mM imidazole. Cap1, but not IncA, preferentially co-eluted with Mcsc. Ponceau staining of nitrocellulose membrane indicate levels of Mcsc
eluted from beads. (E). The central region of Ct618 and Cap1 mediate binding to Mcsc. The Mcsc binding domains of Ct618 and Cap1 were mapped by
Y2H analysis. Positive interactions were assessed by activation of GAL4-dependent HIS3 and ADE2 reporter genes and growth in media lacking
histidine (H) or adenine (A). Growth on media lacking tryptophan (T) and leucine (L) are shown as controls for maintenance of the Y2H vectors.
Cartoon schematic shows Mcsc binding region maps adjacent to the large hydrophobic region at the COOH-terminus of these inclusion membrane
proteins.
doi:10.1371/journal.ppat.1000579.g003
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Greater than 10% of the Chlamydia genome is predicted to
encode for substrates of T3S [14,54]. This arsenal of effectors is
required for efficient cell invasion, establishment of the inclusion,
acquisition of nutrients, and avoidance of innate immune
responses. How these highly adapted pathogens coordinate the
secretion of effector proteins is largely unknown. In one model, a
hierarchy of effector secretion is established by the timing of their
synthesis. In this manner, temporal gene expression over the early,
mid and late cycles dictates effector delivery [14,55]. One caveat
with this model is that early cycle genes continue to be expressed
throughout infection [55]; therefore, all effectors are theoretically
present by mid-late cycle (,20 h for urogenital C. trachomatis
serovars). The presence of early, mid and late effectors competing
to engage a common injectisome would argue that additional
components are involved to ensure an orderly translocation of
effectors. How do mid-late effectors compete for efficient transport
given that all these effectors must engage a common injectisome?
Most effector proteins contain a T3S targeting signal at their
extreme amino terminus that is broadly recognized by divergent
injectisomes. Additional targeting information contained within
approximately the first 200 amino acid residues of the effector
provides binding sites for secretion chaperones [44,56,57]. These
chaperones are multi-functional: they target effectors to the proper
injectisome, stabilize pre-formed effector proteins, mask mem-
brane targeting domains prone to aggregation and possibly impart
a translocation hierarchy [43,58,59]. T3S chaperones are small,
acidic proteins that display a conserved a2b2a fold and form
stable homo- and heterodimers [60]. These dimers bind to
partially unfolded effector proteins via a hydrophobic patch
formed by residues on the a1, b1 and b4-5 strands [44].
Despite the limited homology among T3S chaperones, six
potential C. trachomatis chaperones can be identified based on
primary amino acid sequences: Ct043, Scc1 (Ct088), Scc2 (Ct568),
Scc3 (Ct860), Ct274 and Ct663 [61]. To identify their potential
effector cargo, we screened for interacting chlamydial proteins by
Y2H analysis. We confirmed previously reported interactions
between Scc2 and CopB, and Scc3 and CopN [24,31] (Fig. 1C). In
addition, we identified a novel interaction between Scc2 and
CopD and determined that Ct274 may interact with two small
acidic proteins, Ct161 and Ct668 (Fig. 1C). Ct668, encoded within
an operon of structural injectisome components, was previously
identified in a screen for proteins exported from the inclusion [28].
PSI-BLAST analysis indicates that Ct668 is related to a large
family of hypothetical DNA-binding proteins, raising the intrigu-
ing possibility that Ct668 is a transcriptional regulator. Whether
Ct668 is a chaperone, a core T3S component, or a regulatory
factor remains to be determined.
Given the large number of effectors and the dearth of T3S
chaperone interacting partners identified by bioinformatics, we
hypothesized that many secretion accessory factors remained to be
found. We speculated that these factors may act as adaptors
between effector proteins and components of the injectisome. In a
subgenomic interactome map of the T3S apparatus, CdsQ
emerged as a central node of protein-protein interactions
(Fig. 1D). Based on its homology to FliN and Spa33, CdsQ is
predicted to form the C-ring, a large protein scaffold at the base of
the injectisomes. Interestingly, many of the CdsQ interacting
factors we identified are conserved among injectisomes [18],
suggesting small deviations in the basic architecture of this
secretion apparatus despite the large evolutionary distance
between Chlamydiales and other Gram-negative bacteria [17].
We identified two novel hubs of protein-protein interactions
(Ct260 and Ct700) that linked multiple inclusion membrane
proteins to the secretion apparatus (Fig. 1D). Ct260/Mcsc was of
particular interest because, in addition to its direct interaction with
CdsQ and many secretory cargo proteins (Cap1, Ct225 and
Figure 4. Effector protein stability is linked to Mcsc function. (A). Schematic of T7 expression vectors used to test the effect of Mcsc in Ct618 and
Cap1 expression (B). Ct618 and Cap1 display altered mobility in the presence of Mcsc. Ct618 and Cap1 were expressed with or without Mcsc and total
proteins (,30 mg) were analyzed by immunoblots with specific antibodies. Note decreased levels of expression and altered sizes of Cap1 and Ct618
in the absence of Mcsc. (C–E) Mcsc mutations in the putative effector binding domain disrupt cargo binding and destabilize Cap1 and Ct618.( C). Point
mutations in the putative effector binding regions of class I chaperones [44] were generated in the a1 (L15A) and b1 strand (L31, L33 & L35 to A or G)
either in Y2H (D)o ri nE. coli expression vectors (E). (D). All Mcsc mutants disrupted the Y2H interactions between Mcsc and Cap1 and Ct618. (E). E.
coli co-expressing 6xHis-tagged Ct618 or Cap1 with Mcsc mutants were monitored for steady-state expression of recombinant proteins and co-
purification on Ni
2+ agarose beads. Mutations in the Mcsc b1 strand led to substantially lower steady-state levels of Ct618 and Cap1. In contrast, L15A
mutants altered Ct618, but not Cap1, stability.
doi:10.1371/journal.ppat.1000579.g004
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to other T3S chaperones (Fig. S1). Mcsc is expressed in both
developmental forms of Chlamydia (Fig. 2C) and forms stable
dimers and complexes with at least two inclusion membrane
proteins (Fig. 3A–D). In E. coli, significantly lower levels of Ct618
and Cap1 were observed in the absence of Mcsc or when Mcsc
was mutated to impair effector protein binding (Fig. 4B, D, E).
These findings suggest that one of the functions of Mcsc is to
stabilize these inclusion membrane proteins. While the data
presented here implies that Mcsc acts as a bona fide Class I T3S
chaperone, at present we cannot assign a role for Mcsc in directing
the secretion of Cap1 or Ct618. Proof of such a role will require
the development of a proper system for genetic manipulation in
Chlamydia or the reconstitution of chaperone-dependent secretion
in a heterologous T3S system.
In S. typhimurium, the SptP-SicP effector chaperone complex
binds to the conserved ATPase InvC [45]. InvC then dissociates
this complex and provides the energy required for the transloca-
tion of the SptP across the injectisome. A similar role for the
ATPase in substrate selection by chaperone binding has been
proposed for the EPEC T3S system and flagellar export [62]. By
analogy to these findings, we propose that CdsQ recruits Mcsc-
effector complexes directly to the base of the injectisome (Fig. 6).
However, because Mcsc can bind to the C-ring component CdsQ
in the absence of its bound substrate (Fig. 5A), it is also possible
that Mcsc is pre-docked on the C-ring of the injectisome. This
latter possibility is consistent with the observation that Mcsc
partitions with inner membranes in EBs (Fig. 2D) in the absence of
its cognate cargo, which are not synthesized until after 1 h (Cap1)
and 8 h (Ct618) post invasion [55]. Because the stability of
effectors require binding by Mcsc, either Mcsc dimers detach from
the injectisome and bind to newly synthesized effectors at distal
sites or the translating ribosome itself is recruited to the C-ring. In
support of a localized translation model, the chlamydial GTPase
(HflX) that binds to the 50S ribosome subunit, localizes to the
bacterial inner membrane [63], suggesting that some ribosomes
may be pre-docked at secretion sites. Furthermore, one of the
CdsQ-interacting proteins identified by Y2H is Ct677, a putative
ribosome recycling factor (Fig. 1D). These findings raise the
intriguing possibility that the injectisome may interact with the
bacterial translational machinery. As an obligate intracellular
pathogen, it would not be surprising if the chlamydial injectisome,
the main portal for communication with the host, is hard wired to
interface with the bacterial and transcriptional and translational
machinery. Such a system would allow for rapid regulation of
effector protein translocation in response to intracellular (patho-
gen’s metabolic status, developmental cues) and extracellular (host
responses, inclusion lumen environment) signals.
The prominence of CdsQ as a hub of protein-protein
interactions, including secretion chaperones, suggests a central
role in regulating the recognition of effector proteins. In the
flagellar system, the CdsQ-related C-ring component FliM binds
to the flagellar general chaperone FliJ [64]. Similarly, the Shigella
CdsQ homologue, Spa33, can be co-isolated with effector proteins
indicating that recognition of chaperone-effector complexes by C-
ring components may be evolutionarily conserved [38]. Based on
these observations and our own findings with the Chlamydia
injectisome, we hypothesize that proteins at the base of the
translocon integrate multiple intracellular signals to regulate the
production and secretion of virulence factors. Interestingly, in the
flagellar systems, the C-ring protein FliG was recently shown to
Figure 5. Mcsc-effector complexes bind to CdsQ, the C-ring
component of the injectisome. (A). CdsQ binds to Mcsc. Recombi-
nant GST or GST-CdsQ coupled to glutathione Sepharose beads was
incubated with 6xHis-tagged Mcsc dimers. Bound proteins were eluted
with 5 mM reduced glutathione and analyzed by SDS PAGE followed by
Sypro Orange staining and immunoblots (IB). Arrowheads mark GST-
CdsQ, GST and 6xHis-Mcsc. Mcsc was preferentially co-precipitated in
the presence of CdsQ. (B). CdsQ binds to Mcsc-Cap1 effector complexes.
Pull-down assays were done as in (A) but using Mcsc/Cap1-6xHis
protein complexes purified by gel filtration chromatography (Fig. 3C).
By immunoblot analysis, Mcsc/Cap1 protein complex co-purified only in
the presence of GST-CdsQ.
doi:10.1371/journal.ppat.1000579.g005
Figure 6. Model of Mcsc recognition by the Chlamydia injecti-
some. The inclusion membrane proteins Cap1 and Ct618 in complex
with Mcsc dimers engage the C-ring of the injectisome (CdsQ). These
docked complexes are presumably placed in proximity to the ATPase
CdsN to initiate secretion of the effector proteins. HP: Hydrophobic
patches common to many inclusion membrane proteins (Inc).
doi:10.1371/journal.ppat.1000579.g006
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rotation in response to fumarate [65]. These findings suggest that
in addition to the recognition of secretion substrates, the C-ring
may provide a mechanism for the integration of intracellular cues
by binding to ‘‘sensor’’ proteins not typically thought to be
associated with T3S (e.g. envelope assembly, intermediary
metabolism, stress). Global screens for proteins that interact with
components at the base of the injectisome, such as those described
in this study, should help elucidate the intricacies of T3S function
and regulation.
Materials and Methods
Bacterial strains and plasmids
Bacteria, yeast strains and plasmids are listed in Supplementary
Table S3. C. trachomatis ORFs were amplified from purified C.
trachomatis serovar D genomic DNA using the primers listed in
Table S3 and the Expand High Fidelity PCR system (Roche).
PCR products were subcloned into pET24d, pET15b (Novagen)
and/or pGEX-4T1 (Invitrogen). Mutation sites, L15RA, 3A (I31,
I33, V35RA) and 3G (I31, I33, V35RG), were chosen based on
sequence alignments of several T3S chaperones (Fig. 4C & S1) and
site directed mutagenesis was performed with QuickChange Kit
(Stratagene) as instructed by the manufacturer. Mcsc/Cap1-
6xHis, Mcsc/Ct618-6xHis and Mcsc(L15A, 3A or 3G)/Ct618-
6xHis were vo-expressed as a bicistronic construct in pET-24d(+).
Affinity-tagged recombinant proteins were expressed in E. coli
BL21 DE3 (Stratagene) with 0.5 mM IPTG.
Creation of Y2H strains library and Y2H screens
The Matchmaker Two-Hybrid System (Clontech) was used in
this screen. C. trachomatis genes (CT) were amplified from a
previously established chlamydial ORF library [28] using the
pGAD and pGBT9 primers or directly from genomic DNA using
ORF specific primers (Table S3) with Expand High Fidelity
polymerase. PCR products were transformed into both Y2H
reporter yeast strains PJ69-4a (MATa) or AH109 (MATa) along
with digested Y2H vectors pGAD424 or pGBT9 by the lithium
acetate method [66]. MATa yeast strains containing C. trachomatis
ORFs inserted into pGAD424 were arrayed in 96 well plates. This
ordered array of yeast strains was mated against individual MATa
yeast strains containing pGBT9-CT ORFs. The resulting diploids
were selected in synthetic complete (SC) medium lacking leucine
and tryptophan. Yeast matings were performed semi-automati-
cally with a RoboMEK-FX (Beckman-Coulter) liquid handler.
Positive interactions were assessed by monitoring growth on SC
media lacking histidine (His) or adenine (Ade) over 4 days.
Cell culture conditions and propagation of C. trachomatis
HeLa cell monolayers were grown in Dulbecco’s minimal
essential medium (DMEM)(Gibco) supplemented with 10% fetal
bovine serum (Mediatech) at 37uC/5% CO2. C. trachomatis LGV
(serotype L2) EBs were purified by density gradient centrifugation
as previously described [51]. Infections were initiated by adding
EBs to HeLa monolayers (multiplicity of infection (MOI) ,1)
followed by centrifugation at 3,5006g for 25 min at 10uC.
Generation of antibodies and immunodetection
methods
GST-Mcsc, GST-CdsQ and GST-Ct618 (aa1–96) were ex-
pressed in E. coli and purified with glutathione coated Sepharose 4-
Fast Flow beads (GE Healthcare) at 4uC for 2 hr. Recombinant
GST-Mcsc was eluted with 20 mM reduced glutathione in PBS
(pH 8.0) and used to immunize female White New Zealand rabbits
(5,6 lbs) (Robinson Services, Inc.). Antisera was depleted of anti-
GST antibodies and affinity purified over a GST-Mcsc or GTS-
CdsQ column. Bound antibodies were eluted with 0.2 M Glycine
(pH 2.5) and neutralized with 1 M K2HPO4. The resulting
antibodies was then dialyzed in PBS and stored in 280uC. For
immunoblot analysis, protein samples were separated by SDS-
PAGE, transferred to 0.45 mm nitrocellulose membranes and
blocked in 2% non-fat powder milk in TBST (50 mM Tris-Base,
150 mM NaCl, 0.2% Tween pH 7.4). Membranes were incubated
with primary antibody diluted in 1% milk-TBST, followed by
incubation with secondary antibody conjugated to horseradish
peroxidase and detection by chemiluminescence (Pierce). Primary
antibodies include anti-Tarp (T. Hackstadt, RML), Hsp60,
MOMP and CdsJ (K. Fields, U. of Miami), Cap1 (A. Subtil,
Pasteur Institute), RpoD (M. Tang, UC Irvine), actin (Sigma-
Aldrich), a-tubulin (Sigma-Aldrich), hexahistidine (Rockland Inc.)
and IncA (generated in our laboratory).
For indirect immunofluorescence detection, HeLa cells were
seeded on glass coverslips and infected at MOI,1 for the
indicated times. Infected cells were fixed in methanol, blocked
with 2% bovine serum albumin (BSA) in PBS and incubated with
polyclonal anti-Mcsc, CdsQ, Ct618 or Cap1 antibodies (1:100 in
PBS/2% BSA) and mouse monoclonal anti-MOMP antibodies
(RDI) (1:300 in PBS/2% BSA) for 1 hr at 4uC. Immunoreactive
material was detected with Alexafluor conjugated secondary
antibodies (Invitrogen, CA). Images were acquired with a Leica
TCS SL confocal microscope and processed with Leica imaging
software.
Subcellular fractionations
Outer membrane complexes. Density gradient purified
EBs were solubilized in 2 mls of Sarcosyl extraction buffer (PBS
pH 7.4, 2% Sarcosyl, 1.5 mM EDTA) at 37uC for 1 h. The
resulting lysates were centrifuged at 100,0006g for 1 h at 4uC.
Sarcosyl-insoluble pellets (Chlamydia Outer Membrane complexes-
COMC [51]) were washed three times in Sarcosyl extraction
buffer. COMC pellets were resuspended in PBS pH 7.4/10 mM
MgCl2 and incubated with 25 mg of DNase at 37uC for 2 hrs.
COMC pellets were centrifuged as described above and
resuspended in PBS. Sarcosyl insoluble and soluble protein
fractions were acetone precipitated and resuspended in SDS-
PAGE loading buffer prior to immunoblot analysis.
Triton X114 fractionation of membrane proteins. EBs
(,10
10 IFUs) were centrifuged at 20,0006g for 5 min at 4uC,
resuspended in 50 ml of PBS/5 mM dithiotheritol (DTT) for
10 min at 4uC, and integral membrane proteins were extracted
using 1% Triton-X114 as previously described [50]. The resulting
aqueous fraction containing cytoplasmic proteins and the
detergent fraction containing membrane proteins were acetone
precipitated and resuspended in SDS-PAGE loading buffer.
In vitro induction of T3S. InvitrosecretionofT3Ssubstrates
was performed as described [52]. Briefly, density gradient purified
EBs werewashed 5 times in potassium acetate (KAc) buffer (50 mM
potassiumacetate,pH 4.8) andresuspended inKAcwithorwithout
0.5% BSA/10 mM EGTA. After 30 min incubation at 37uC,
bacteria were centrifuged at 20,0006g for 5 min at 4uC.
Supernatants were re-centrifuged and the secreted proteins in the
clarified samples were subjected to immunoblot analysis.
Biochemical analysis of Mcsc
Crosslinking. Purified 6xHis-Mcsc was treated with the
reversible chemical crosslinker DSP (dithiobis[succinimidylpro-
pionate]) (Pierce) at concentrations between 0.25–1 mM in
Dimethyl sulfoxide (DMSO). After 20 min incubation at 4uC,
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devoid of reducing agents. The samples were divided equally and
50 mM dithiothreitol (DTT) was added to half of the samples.
Samples were analyzed by immunoblot.
Purification of Mcsc and Mcsc/effector protein com-
plexes. Mcsc, Ct618-Mcsc, and Cap1-Mcsc complexes were
purified from bacteria expressing pET15b-Mcsc, pET-24d-Mcsc/
Cap1 or pET24d-Mcsc/CT618 by incubation of clarified
supernatants with Ni
2+-nitriloacetic acid (NTA) agarose beads
(Qiagen, Ca). Beads were washed 4 times with wash buffer
(50 mM Phosphate buffer pH 8.0, 150 mM NaCl, 10 mM
Imidazole) and recombinant proteins were eluted with 460.5 ml
of 50 mM Phosphate Buffer containing 150 mM NaCl
and150 mM imidazole. Co-eluted proteins were identified by
Coomasie staining and immunoblots with anti-Mcsc and anti-
6xHis antibodies. For gel filtration, hexahistidine-tagged Mcsc,
Cap1/Mcsc or CT618/Mcsc protein samples were loaded on a
16/60 Sephacryl S-100 HR column (GE Healthcare) and proteins
eluted in 10 mM Tris-HCl/50 mM phosphate Buffer/150 mM
NaCl pH 8.0 at a flow rate of 0.5 ml/min and at a pressure of
0.5 MPa. Proteins were collected in fraction sizes of 2.5 ml and
detected with anti-6xHis or the anti-Mcsc antibodies. Size of the
eluted complexes was determined with a low molecular weight gel
filtration calibration kit (GE Healthcare).
Mcsc-Cap1 pull-down assays. HeLa cell monolayers were
infected with C. trachomatis serovar L2 at an MOI of ,5 for
28 hours, lysed in 1% NP40 (50 mM Tris pH 7.5, 50 mM NaCl,
1 mM PMSF, protease inhibitor cocktail). Approximately 400 mg
of lysates from infected or uninfected cells were incubated with
50 mg of purified 6xHis-Mcsc at 4uC for 30 min and isolated with
Ni
2+-NTA agarose beads. The beads were washed five times with
binding buffer and bound proteins were subjected to immunoblot.
GST-CdsQ binding assays
Freshly purified GST or GST-CdsQ coupled to glutathione
sepharose beads was incubated with 6xHis-Mcsc dimers or Mcsc/
Cap-6xHis complexes purified by gel filtration and incubated
overnight at 4uC in binding buffer (50 mM Tris-HCl, 150 mM
NaCl, 2 mM EDTA and 0.5% TritonX-100) After extensive
washing, bound proteins were eluted with 25 mM glutathione and
subjected to SDS PAGE followed by staining with Sypro orange
(Molecular Probes) and detection with a Typhoon 9410 Phos-
phoimager, (GE Healthcare). Parallel samples were analyzed by
immunoblot.
Supporting Information
Table S1 Summary of chlamydial genes characterized by yeast
two-hybrid analysis
Found at: doi:10.1371/journal.ppat.1000579.s001 (0.36 MB
DOC)
Table S2 Summary of Y2H-based protein-protein interactions
identified between chlamydial proteins
Found at: doi:10.1371/journal.ppat.1000579.s002 (0.18 MB
DOC)
Table S3 Strains, plasmids and primers
Found at: doi:10.1371/journal.ppat.1000579.s003 (0.06 MB
DOC)
Figure S1 Mcsc structural models. A–C. Predicted three
dimensional structure of Mcsc. A putative 3D model of Mcsc
(yellow) was generated with the neural network folding prediction
program I-TASSER (http://zhang.bioinformatics.ku.edu/I-TAS-
SER/) [1]. Modeling of Mcsc and SigE structure were performed
with PyMOL (http://www.pymol.org/). Overlay of Mcsc mono-
mers (A) on SigE (magenta) monomers and dimers (blue) (B), and a
model of a Mcsc dimer (C). D. Conservation among amino
terminal residues in Class I T3S chaperones required for effector
protein binding. Conserved amino acids (blue) in Mcsc align with
a-helix and b-strand 1 as assessed by secondary structure
predictions performed with PSIPRED (http://bioinf.cs.ucl.ac.
uk/psipred/).
Found at: doi:10.1371/journal.ppat.1000579.s004 (3.34 MB TIF)
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